Combined angiotensin inhibition for the treatment of diabetic nephropathy. - Wikidata - wikimedia - TriplyDB

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

http://www.wikidata.org/entity/Q46129784

about

Interactions between kidney disease and diabetes: dangerous liaisons Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes Recent advances in managing and understanding diabetic nephropathy Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses Recent advances in treatment of heart failure Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses An Update on the Use of Animal Models in Diabetic Nephropathy Research Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system The Prevalence and Management of Diabetic Nephropathy in Asia Present and future in the treatment of diabetic kidney disease De novo glomerular diseases after renal transplantation Mechanisms of disease reversal in focal and segmental glomerulosclerosis Diabetic kidney disease: a report from an ADA Consensus Conference Diabetic kidney disease: from physiology to therapeutics Improvements in the Management of Diabetic Nephropathy Meta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on Albuminuria Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy Mitochondrial hormesis and diabetic complications Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful End Point in Randomized Clinical Trials.Clinical therapeutic strategies for early stage of diabetic kidney disease.Heart failure: New data do not SUPPORT triple RAAS blockade.Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data.Renal lesions in patients with type 2 diabetes: a puzzle waiting to be solved.Lipid, blood pressure and kidney update 2013.C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.The impact of antihypertensives on kidney disease.Cardiovascular complications of diabetic kidney disease.Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)Acute kidney injury: quoi de neuf?Diabetic nephropathy for the primary care provider: new understandings on early detection and treatment A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design.Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.Diabetic nephropathy - complications and treatment.From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action.

P2860

Q26740630-EAB9B7C4-CEC1-4C66-A022-436BEB1BF5E5 Q26744419-5F70EA8E-C811-4312-8B27-1F08A4DF51AF Q26745900-F0A686F9-514A-4B22-88EC-C6CD086D5FB9 Q26765228-6A871A31-6188-4E9F-AE69-1D3F5C9FA670 Q26766025-251E8D83-7EA2-4D5B-8480-51ED4FBAB077 Q26766223-6E817E04-9A2E-4B5D-A9D7-135E08A874D8 Q26767278-AB53D397-1E9F-4CC4-88D2-1AC5ACA8DA27 Q26774178-C7BBD229-F505-485A-93D2-496E20BD9E88 Q26795398-D1C63D8D-A152-426D-B878-70D1854C2786 Q26799443-9E6B5DA8-D314-4545-99C9-B817A80C4953 Q26822500-239D0C92-D7D5-43C8-B006-2F4BA4338D4B Q26851262-45E429D1-17D5-4540-B44F-E2CA56700666 Q26864133-87B1D310-8FE8-46F1-A9EC-D44E661FEB2C Q27005877-B25203C3-8C8B-4C7C-BC9B-8C49F8E9E115 Q27010135-2356658E-BECD-450F-BD67-5D04D4849114 Q27012546-487A6FF0-E8CE-4FDD-B1C1-985E38215C41 Q27021392-E4BA8149-9EFB-46EB-9A2D-2554D7257491 Q28080717-BD8317AB-4C5D-42D3-8BBD-99D83A6FB3C8 Q28085248-F8D6E9DD-D8BF-4FF8-B417-4451A84CA59D Q28246398-648A8023-2732-4751-8060-B9790EDFC335 Q28354224-7875841E-2D94-4D24-A691-5A8569F3E0E2 Q28388387-D0E948BD-AC4D-4064-BEB5-4AE8A8DE3E33 Q28566503-EF26A890-6BF1-4069-9A26-24E1B7883DE6 Q30251988-1AD6B12A-A363-4A6F-A750-085A211422FF Q30363683-177A4FAB-64FD-4086-91B5-77C960EA73D9 Q30914698-41A2CEE0-6704-4CAE-9637-B58460329385 Q31131772-C6D54387-8332-4B30-9A18-68037E889EE4 Q33359672-5317B632-9146-4F7C-9ECE-71683D76615A Q33574532-FE95EF20-4ADF-431B-AC66-1CE4030DE47F Q33620560-96F3173F-1460-4708-BF46-AFFF32074A83 Q33632021-5AEE5EB0-1F4D-45DA-B571-AD956BD6FC8B Q33711038-BEE31321-061F-4AD6-A506-50CAECC54BE6 Q33799767-5E9519E4-3775-4261-8E0B-3924DADB5A09 Q34219430-5F2BFA29-8E06-44CE-AA9E-C70FB5E9355A Q34228579-DAB6BCB2-6CA7-4F1A-AC0B-FC491274A368 Q34228586-6E699BF0-4D89-4DD6-8074-76B1F9744B6D Q34273029-30EA1F65-9D89-4B8C-B3EA-EE11ECE4A37D Q34383685-30CB4467-E5CA-4699-90B1-28E671C56986 Q34387952-5868A8BD-F182-452C-B8B4-ED8ACB833099 Q34391213-9909770E-C84F-4DF0-AB37-8A86F5569031

P2860

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

http://www.wikidata.org/entity/Q46129784

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

@en

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

@nl

type

label

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

@en

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

@nl

prefLabel

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

@en

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

@nl

P1433

Q46129784-EEF3115B-27C6-435C-93CB-EC60FA7AC8AA

P1476

Q46129784-14E11BFF-CA69-41F0-8DFB-8D633D966A57

P2093

Q46129784-052C1B0A-6A70-4DD5-AE8E-EE34D97C191D

Q46129784-073B27A6-6CFC-412A-842F-8FC4C0A028CA

Q46129784-1F06FB7F-03A0-41DE-A64A-91378E73E742

Q46129784-3747CF4A-8779-4682-90D3-DC4C4B153C6A

Q46129784-4727E165-2F97-4C1D-86E9-DDAFD2D87EBF

Q46129784-4ED10093-0A66-4E4E-9163-6CF9113DA0D4

Q46129784-59DC82B1-D2BD-48DC-AE65-19D81C8FB21D

Q46129784-617A6A7F-622A-4466-B1A2-6CC1800FE907

Q46129784-66136ADA-2A23-49E8-9ABB-9EF0773B597B

Q46129784-878A2DAC-8CFA-40F1-B344-ED18081E4B0A

P304

Q46129784-9007C4D9-EA55-4554-B3C2-7A6EC3018F62

P31

Q46129784-BB1DA9EA-9A1F-4A83-A9E8-28A0990F28F6

P356

Q46129784-4FCCD355-C4C5-4E7C-9F50-49C15FF401C9

P407

Q46129784-8E24CFCE-8F17-429A-9EDC-36C078CAB7C4

P433

Q46129784-B4BF2639-6B72-430D-9E4D-AD2444E724E8

P478

Q46129784-7133FC71-9E6E-47F0-84E4-8443397C84B9

P577

Q46129784-440272AE-D211-4877-9A40-992134FE5FA3

P698

Q46129784-64CCAC7D-390D-4630-9D66-CACD7CB97185

P356

P1433

The New England Journal of Medicine

P1476

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

@en

P2093

David J Leehey

http://www.w3.org/2001/XMLSchema#string

Jane H Zhang

http://www.w3.org/2001/XMLSchema#string

Linda F Fried

http://www.w3.org/2001/XMLSchema#string

Mary Brophy

http://www.w3.org/2001/XMLSchema#string

Nicholas Emanuele

http://www.w3.org/2001/XMLSchema#string

Paul M Palevsky

http://www.w3.org/2001/XMLSchema#string

Peter A McCullough

http://www.w3.org/2001/XMLSchema#string

Peter Guarino

http://www.w3.org/2001/XMLSchema#string

Peter Peduzzi

http://www.w3.org/2001/XMLSchema#string

Robert F Reilly

http://www.w3.org/2001/XMLSchema#string

P304

1892-1903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1303154

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24206457

http://www.w3.org/2001/XMLSchema#string